Search Results

Filter
  • 1-10 of  24 results for ""Cyclic Nucleotide Phosphodiesterases, Type 3""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A selective phosphodiesterase 3 inhibitor rescues low PO2-induced ATP release from erythrocytes of humans with type 2 diabetes: implication for vascular control.

  • Authors : Sprague RS; Department of Pharmacological and Physiological Science, Saint Louis University School of Medicine, Missouri 63104, USA. ; Bowles EA

Subjects: Adenosine Triphosphate/Adenosine Triphosphate/Adenosine Triphosphate/*blood ; Cyclic Nucleotide Phosphodiesterases, Type 3/Cyclic Nucleotide Phosphodiesterases, Type 3/Cyclic Nucleotide Phosphodiesterases, Type 3/*blood ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*blood

  • Source: American journal of physiology. Heart and circulatory physiology [Am J Physiol Heart Circ Physiol] 2011 Dec; Vol. 301 (6), pp. H2466-72. Date of Electronic Publication: 2011 Sep Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901228 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Gallic acid isolated from Spirogyra sp. improves cardiovascular disease through a vasorelaxant and antihypertensive effect.

  • Authors : Kang N; Department of Marine Life Sciences, Jeju National University, Jeju 690-756, Republic of Korea.; Lee JH

Subjects: Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/*pharmacology ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*pharmacology ; Antioxidants/Antioxidants/Antioxidants/*pharmacology

  • Source: Environmental toxicology and pharmacology [Environ Toxicol Pharmacol] 2015 Mar; Vol. 39 (2), pp. 764-72. Date of Electronic Publication: 2015 Feb 16.Publisher: Elsevier Science B.V Country of Publication: Netherlands NLM ID: 9612020 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Differential vasodilation response to olprinone in rabbit renal and common carotid arteries.

  • Authors : Minonishi T; Department of Anesthesiology, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-0012, Japan.; Ogawa K

Subjects: Phosphodiesterase 3 Inhibitors*; Carotid Artery, Common/Carotid Artery, Common/Carotid Artery, Common/*drug effects ; Imidazoles/Imidazoles/Imidazoles/*pharmacology

  • Source: Journal of anesthesia [J Anesth] 2010 Feb; Vol. 24 (1), pp. 61-6.Publisher: Springer International for the Japan Society of Anesthesiology Country of Publication: Japan NLM ID: 8905667 Publication Model: Print Cited

Record details

×
Academic Journal

Cardiovascular toxicity of minoxidil in the marmoset.

  • Authors : Hanton G; Department of Toxicology and Comparative Medicine, Pfizer Global Research and Development, Z.I. Pocé-sur-Cisse, BP 159, F-37401 Amboise Cedex, France. ; Sobry C

Subjects: Callithrix/Callithrix/Callithrix/*physiology ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*chemically induced ; Minoxidil/Minoxidil/Minoxidil/*toxicity

  • Source: Toxicology letters [Toxicol Lett] 2008 Aug 28; Vol. 180 (3), pp. 157-65. Date of Electronic Publication: 2008 Jun 05.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7709027 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0378-4274

Record details

×
Academic Journal

NT-702, a selective phosphodiesterase 3 inhibitor, dilates rabbit spinal arterioles via endothelium-dependent and endothelium-independent mechanisms.

  • Authors : Mizuno R; Department of Physiology, Shinshu University School of Medicine, Matsumoto, 390-8621 Japan.; Watanabe S

Subjects: Phosphodiesterase 3 Inhibitors*; Endothelium, Vascular/Endothelium, Vascular/Endothelium, Vascular/*drug effects ; Phosphodiesterase Inhibitors/Phosphodiesterase Inhibitors/Phosphodiesterase Inhibitors/*pharmacology

  • Source: The journal of physiological sciences : JPS [J Physiol Sci] 2008 Aug; Vol. 58 (4), pp. 229-37. Date of Electronic Publication: 2008 Jun 18.Publisher: Springer Japan Country of Publication: Japan NLM ID: 101262417 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1880-6546

Record details

×
Academic Journal

Cilostazol in the management of vascular disease.

  • Authors : Dalainas I; Unit of Vascular Surgery, University of Milan, Milan, Italy.

Subjects: 3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/*antagonists & inhibitors ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*drug therapy ; Endothelium, Vascular/Endothelium, Vascular/Endothelium, Vascular/*drug effects

  • Source: International angiology : a journal of the International Union of Angiology [Int Angiol] 2007 Mar; Vol. 26 (1), pp. 1-7.Publisher: Minerva Medica Country of Publication: Italy NLM ID: 8402693 Publication Model: Print Cited Medium: Print ISSN: 0392-9590 (Print)

Record details

×
Academic Journal

Inhibitors of cyclic nucleotide phosphodiesterase 3 and 5 as therapeutic agents in heart failure.

  • Authors : Stehlik J; University of Utah School of Medicine, Cardiology Section, VA Salt Lake City Healthcare System, 500 Foothill Boulevard, Salt Lake City, UT 84117, USA. ; Movsesian MA

Subjects: 3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/3',5'-Cyclic-AMP Phosphodiesterases/*antagonists & inhibitors ; 3',5'-Cyclic-GMP Phosphodiesterases/3',5'-Cyclic-GMP Phosphodiesterases/3',5'-Cyclic-GMP Phosphodiesterases/*antagonists & inhibitors ; Cardiotonic Agents/Cardiotonic Agents/Cardiotonic Agents/*therapeutic use

  • Source: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2006 Jul; Vol. 15 (7), pp. 733-42.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print Cited Medium: Internet ISSN: 1744-7658

Record details

×
Academic Journal

Levosimendan, a new inotropic and vasodilator agent.

  • Authors : Toller WG; Department of Anesthesiology and Intensive Care Medicine, Medical University Graz, Austria. ; Stranz C

Subjects: Cardiotonic Agents/Cardiotonic Agents/Cardiotonic Agents/*pharmacology ; Hydrazones/Hydrazones/Hydrazones/*pharmacology ; Pyridazines/Pyridazines/Pyridazines/*pharmacology

  • Source: Anesthesiology [Anesthesiology] 2006 Mar; Vol. 104 (3), pp. 556-69.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 1300217 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

[Levosimendan].

  • Authors : Michels G; Klinik III für Innere Medizin, Universität zu Köln.; Herzig S

Subjects: Cardiotonic Agents*/Cardiotonic Agents*/Cardiotonic Agents*/pharmacokinetics ; Cardiotonic Agents*/Cardiotonic Agents*/Cardiotonic Agents*/pharmacology ; Cardiotonic Agents*/Cardiotonic Agents*/Cardiotonic Agents*/therapeutic use

  • Source: Deutsche medizinische Wochenschrift (1946) [Dtsch Med Wochenschr] 2005 Oct 28; Vol. 130 (43), pp. 2444-6.Publisher: G. Thieme Country of Publication: Germany NLM ID: 0006723 Publication Model: Print Cited Medium: Print ISSN: 0012-0472 (Print)

Record details

×
Academic Journal

Calcium sensitizers, a new class of inodilators.

  • Authors : Kwak YL; Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea.

Subjects: Calcium/Calcium/Calcium/*physiology ; Cardiotonic Agents/Cardiotonic Agents/Cardiotonic Agents/*pharmacology ; Vasodilator Agents/Vasodilator Agents/Vasodilator Agents/*pharmacology

  • Source: International anesthesiology clinics [Int Anesthesiol Clin] 2005 Spring; Vol. 43 (2), pp. 115-33.Publisher: Lippincott WIliams & Wilkins Country of Publication: United States NLM ID: 0370760 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
  • 1-10 of  24 results for ""Cyclic Nucleotide Phosphodiesterases, Type 3""